Ulisse Biomed Spa
MIL:UBM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ulisse Biomed Spa
MIL:UBM
|
IT |
|
ArcelorMittal SA
AEX:MT
|
LU |
|
Serve Robotics Inc
NASDAQ:SERV
|
US |
|
Tinc Comm VA
XBRU:TINC
|
BE |
|
W
|
Whitemud Resources Inc
XTSX:WMK
|
CA |
|
C
|
Coles Group Ltd
OTC:CLEGF
|
AU |
|
Indian Railway Finance Corp Ltd
NSE:IRFC
|
IN |
|
MacroGenics Inc
NASDAQ:MGNX
|
US |
|
C
|
Credit Suisse Group AG
XBER:CSX
|
CH |
|
Pros Holdings Inc
NYSE:PRO
|
US |
|
Emperador Inc
XPHS:EMI
|
PH |
|
LNA Sante SA
PAR:LNA
|
FR |
Wall St Price Targets
UBM Price Targets Summary
Ulisse Biomed Spa
According to Wall Street analysts, the average 1-year price target for
UBM is 1.52 EUR with a low forecast of 1.5 EUR and a high forecast of 1.56 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is UBM's stock price target?
Price Target
1.52
EUR
According to Wall Street analysts, the average 1-year price target for
UBM is 1.52 EUR with a low forecast of 1.5 EUR and a high forecast of 1.56 EUR.
What is the Revenue forecast for Ulisse Biomed Spa?
Projected CAGR
87%
Over the last 5 years, the compound annual growth rate for Revenue has been 135%. The projected CAGR for the next 3 years is 87%.